EMEA-001150-PIP02-13-M02

Key facts

Invented name
  • Rapibloc
  • Landiobloc
  • Raploc
  • Runrapiq
Active substance
Landiolol (hydrochloride)
Therapeutic area
Cardiovascular diseases
Decision number
P/0273/2018
PIP number
EMEA-001150-PIP02-13-M02
Pharmaceutical form(s)
  • Powder for solution for infusion
  • Concentrate for solution for injection
Condition(s) / indication(s)
Treatment of supraventricular arrhythmias
Route(s) of administration
Intravenous use
Contact for public enquiries
AOP Orphan Pharmaceuticals AG

E-mail: office@aoporphan.com
Tel. +43 1503 7244

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating